What is Waveguide?
Waveguide is the developer of the WaveGuide Formµla, a pioneering battery-operated, portable nuclear magnetic resonance (NMR) device. By miniaturizing complex analytical instrumentation, the company has effectively bridged the gap between laboratory-grade precision and field-ready utility. The platform serves a diverse array of sectors, including medical diagnostics, pharmaceutical quality control, and food safety testing. By removing the requirement for specialized training, Waveguide is democratizing access to high-fidelity material analysis, positioning itself as a critical infrastructure provider for industries where rapid, on-site quantification is essential for operational integrity and regulatory compliance.
How much funding has Waveguide raised?
Waveguide has raised a total of $200K across 1 funding round:
Debt
$200K
Debt (2026): $200K, investors not publicly disclosed
Key Investors in Waveguide
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Waveguide?
With this late-stage capital, Waveguide is poised to scale its manufacturing capabilities and expand its distribution network to meet rising demand for portable analytical tools. The strategic roadmap likely involves deepening market penetration in the healthcare and industrial sectors, where the need for real-time material authenticity and wear detection is paramount. Furthermore, the company is expected to leverage these funds to enhance its software ecosystem, potentially integrating cloud-based data analytics to provide users with actionable insights derived from their on-site testing. As the firm matures, the focus will shift toward establishing long-term service contracts and expanding the application scope of the WaveGuide Formµla to include emerging industrial use cases.
See full Waveguide company page
